An interventional study of Ambient AI Scribe in Well-being at Work and Burnout, sponsored by Washington University School of Medicine. Active, not recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-08-06.
Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 149 studies in Burnout, Psychological with a site in United States — 29 open to participants now, 41 under way, none of them phase 3. Burnout, Psychological · United States.
Among the 149 studies in Burnout, Psychological with a site in United States, this one is the 78th largest by enrollment of the 134 interventional ones that give a count, is one of 16 that started in 2026, is one of 127 with no phase, reaches primary completion later than 14 of the 40 other live ones, and was the 143rd registered.
468 studies on the registry are indexed under Burnout, Psychological; 121 are open to participants now.
Browse Burnout, Psychological studies →29 of the 149 studies in Burnout, Psychological with a site in United States are open now. Recruiting first, the newest first:
University of Texas at Austin · Sites in United States
Ages 18–100
Brigham and Women's Hospital · Sites in United States
Ages 18+
Efforia, Inc · Sites in United States
Ages 18+ · Healthy volunteers
Laureate Institute for Brain Research, Inc. · Sites in United States
Ages 18–64
AdventHealth · Sites in United States
Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 65 Burnout, Psychological studies recruiting now, 43 (66%) set no upper age limit and 16 (25%) stop at 75 or younger; 14 take children under 18; 33 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
149 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 3 · Phase 4 1
First in 2008; this study’s year is marked. 16 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 55 is below the median of 80 across 344 interventional studies indexed under Burnout, Psychological.
Median enrollment 80 across the 134 interventional studies, 50 across the 15 observational. Of the 101 that completed or were terminated, 16 (16%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 149 have an industry lead sponsor. The 10 most frequent:
Washington University School of Medicine is the lead sponsor of 1,806 studies on the registry; 271 are open to participants now.
Of its 329 completed or terminated interventional studies of FDA-regulated products, 216 (66%) have results posted.
Washington University School of Medicine has 2 studies filed under Burnout, Psychological — fewer than ten, so there is no comparison to draw.
16 of the studies in Burnout, Psychological with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07742761Washington University School of MedicineEmergency Medicine Practitioners Overall Well-being Enhancement With Ambient AI Scribes | 2026-12 |
| NCT07773168Brigham and Women's HospitalBurnout and Safety Assessment in Home Hospital Versus Brick-and-Mortar Hospital | 2026-12 |
| NCT07710417Laureate Institute for Brain Research, Inc.FLOAT for Healthcare PTSS | 2026-12 |
| NCT05942469Northwestern UniversityFostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST) | 2026-12-31 |
| NCT07639827Massachusetts General HospitalA Study of a Mental Fitness Intervention for Anesthesiology Resident Wellbeing and Self-Compassion | 2027-01 |
Add all 16 to your calendar (.ics) → With an account.
Among the 149 studies in Burnout, Psychological with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The primary objective of the study is to investigate the impact of an ambient AI scribe on clinicians' wellness and well-being outcomes; additionally, the investigators will also explore how the use of the ambient AI scribe will lead to changes in documentation burden, clinical note characteristics and financial productivity.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-Residents who are apart of the Emergency Medicine Department
Clinicians use an ambient AI scribe during patient encounters to assist with clinical documentation. Wave 1 participants receive the intervention for 18 weeks. Outcomes are compared before and after implementation.
Other: Ambient AI Scribe
Clinicians use an ambient AI scribe during patient encounters to assist with clinical documentation. Wave 2 participants receive the intervention for 12 weeks. Outcomes are compared before and after implementation.
Other: Ambient AI Scribe
Clinicians use an ambient AI scribe during patient encounters to assist with clinical documentation. Wave 1 participants receive the intervention for 6 weeks. Outcomes are compared before and after implementation.
Other: Ambient AI Scribe
Clinicians will use an ambient AI scribe as part of routine clinical care. The AI scribe captures the patient-clinician conversation, generates a draft clinical note, and supports documentation in the electronic health record. Clinicians receive training before beginning use of the AI scribe. The intervention is introduced in three sequential waves using a stepped-wedge design, with all participants eventually receiving the intervention.
Impact of an ambient AI scribe on clinician well-being and professional fulfillment
A linear model will be used to describe the effect of Ambient tool introduction on our co-primary outcomes under the intention-to-treat framework with a random effects structure to describe within provider variability. While high or complete survey completion rates is expected, in the event that not all surveys are completed and returned, a primary analysis on completed surveys only will be performed, and perform sensitivity analyses accounting for potentially systematic survey non-response bias using a response weighting strategy, using provider, scheduling, and patient encounter characteristics to create survey response weights (within each survey time period), then reweighting observations to account for non-response patterns. In analyses for both co-primary outcomes, Wald type hypothesis tests for inferences on the overall Ambient treatment effect and compare p-values to 0.05 / 2 to conservatively account for multiple comparisons using Bonferroni's method will be performed.
Time frame: From enrollment to the end of maintenance phase at 24 weeks
Assessment of the longitudinal changes in documentation burden
The investigators will fit Bayesian generalized linear models with appropriate link functions and likelihood choices (ie, log and Poisson for count data, logit and Bernoulli for binary responses) to for each encounter, while accounting for serial correlation overall through time (indexed to the day) using an autoregressive modeling structure, within provider patterns using a provider level random intercept, weekday, weekend, and holiday effects using fixed effects terms, and specify a flexible interrupted time series treatment effect using a semi-parametric, thin plate spline to describe how the introduction of Ambient AI affects the relationship between providers and notes, and how that relationship evolves over time. In sensitivity analyses, evaluation of how these effects and their evolution may differ by treatment wave will be assessed. All inferences will be based on describing the mean and 95% credible intervals for the treatment effect daily.
Time frame: From enrollment to the end of maintenance phase at 42 weeks
Plan to share: No
Started Apr 2026 (actual). Primary completion is estimated for Dec 2026, 8 months after the start.
Of 253 non-industry interventional studies with no phase under Burnout, Psychological, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 8 months is below that.
Counting every sponsor, half of 260 studies reached it within 12 months; a quarter within 5 and three quarters within 24.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Washington University School of Medicine →